RVMD Stock Tumbles as MRK Reportedly Withdraws Buyout Offer

Key Takeaways RVMD shares fell 17% after a WSJ report said MRK withdrew from buyout talks following a price impasse.The WSJ report said discussions between MRK and RVMD could resume, or another bidder could step in.RVMD is advancing daraxonrasib, with phase III PDAC data and other phase III studies expected this year.Shares of Revolution Medicines (RVMD) slipped 17% yesterday after a Wall Street Journal (WSJ) report said, quoting people familiar with the matter, that pharma bigwig Merck (MRK) was no longer ...